14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
MRX vs PWP: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Marex Group plc (MRX) is the stronger overall head-to-head candidate over Perella Weinberg Partners (PWP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Options & Positioning, R&D & Supply-Chain Moat). MRX carries a Unified Composite Score of 46.1/100 (HOLD) at $70.58 (9.8x Forward P/E, 15.9% operating margin), whereas PWP carries 47.4/100 (HOLD) at $12.89 (8.8x Forward P/E, 8.6% operating margin).
Composite vs. Pillar Nuance: While PWP currently prints a higher short-term Unified Composite Score (47.4/100 HOLD vs. MRX 46.1/100 HOLD), MRX captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (15.9% vs. 8.6% operating margin) and revenue trajectory (+43.1% vs. +52.7% YoY).
Technical & Structure Timing Caution: MRX trades in a Neutral technical trend (BREAKOUT options phase, RSI 52.6); meanwhile PWP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MRX vs PWP. Trailing 12-month operating profitability (MRX 15.9% vs PWP 8.6%) and valuation multiples (MRX 9.8x vs PWP 8.8x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Capital Markets value chain with $1.4B market capitalization and 8.6% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ MRX vs PWP Key Questions & Quantitative Answers
As of Nov 16, 2026, Marex Group plc (MRX) is the stronger overall head-to-head candidate over Perella Weinberg Partners (PWP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Options & Positioning, R&D & Supply-Chain Moat). MRX carries a Unified Composite Score of 46.1/100 (HOLD) at $70.58 (9.8x Forward P/E, 15.9% operating margin), whereas PWP carries 47.4/100 (HOLD) at $12.89 (8.8x Forward P/E, 8.6% operating margin). Composite vs. Pillar Nuance: While PWP currently prints a higher short-term Unified Composite Score (47.4/100 HOLD vs. MRX 46.1/100 HOLD), MRX captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (15.9% vs. 8.6% operating margin) and revenue trajectory (+43.1% vs. +52.7% YoY). Technical & Structure Timing Caution: MRX trades in a Neutral technical trend (BREAKOUT options phase, RSI 52.6); meanwhile PWP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
PWP leads the Growth & Scale pillar: MRX posts +43.1% YoY revenue growth and +62.6% YoY earnings growth on $3.78B TTM revenue (71.5% gross margin, 15.9% operating margin), compared with PWP at +52.7% YoY revenue growth and +153.4% YoY earnings growth on $776M TTM revenue (97.1% gross margin, 8.6% operating margin). On trailing 12-month operating scale, MRX generates $3.78B in USD-normalized revenue versus $776M for PWP. In operating R&D and SG&A reinvestment, MRX deploys 55.6% of Rev ($2.10B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for PWP.
PWP screens cheaper on headline valuation multiples. MRX trades at 9.8x Forward P/E, 13.0x Trailing P/E, N/M PEG, and 4.0x EV/Revenue (unreported cash flow margin), whereas PWP trades at 8.8x Forward P/E, 34.5x Trailing P/E, N/M PEG, and 1.8x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MRX (28.4% ROE) versus PWP (15.2% ROE) capital efficiency.
In options market volatility and institutional positioning, MRX carries 48.3% implied volatility (7th %ile, Compressed (<25th %ile)), a 0.04x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKOUT options structure phase (0.85β · 53% Vol realized risk). By comparison, PWP carries 66.2% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.50β · 55% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.